{"nct_id":"NCT03967223","title":"Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-10","start_date":"2019-12-31","start_date_type":"ACTUAL","primary_completion_date":"2024-03-01","primary_completion_date_type":"ACTUAL","completion_date":"2026-07-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ADAP"]}